According to Calithera Biosciences 's latest financial reports and stock price the company's current Operating Margin is -1,180.38%. At the end of 2021 the company had an Operating Margin of -1,180.39%.
Year | Operating Margin | Change |
---|---|---|
2021 | -1,180.39% | |
2018 | -245.48% | 128.97% |
2017 | -107.21% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | 26.84% | -102.27% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | -79.07% | -93.30% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | -161.15% | -86.35% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.